• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017.1990年至2017年全球、区域、国家、年龄和性别层面特定病因所致原发性肝癌的负担及趋势:全球疾病负担研究2017结果
Liver Cancer. 2020 Sep;9(5):563-582. doi: 10.1159/000508568. Epub 2020 Jul 23.
2
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
3
Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019.1990 年至 2019 年肝癌流行率和病因特异性肝癌的时间趋势。
Clin Res Hepatol Gastroenterol. 2024 Oct;48(8):102451. doi: 10.1016/j.clinre.2024.102451. Epub 2024 Aug 21.
4
Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.中国特定病因引起的原发性肝癌疾病负担的变化趋势。
Cancer Med. 2019 Sep;8(12):5787-5799. doi: 10.1002/cam4.2477. Epub 2019 Aug 6.
5
Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region.亚太地区原发性肝癌的流行病学趋势变化。
Sci Rep. 2024 Aug 22;14(1):19544. doi: 10.1038/s41598-024-70526-z.
6
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.2010 年至 2019 年全球肝癌流行病学变化:NASH 是肝癌增长最快的病因。
Cell Metab. 2022 Jul 5;34(7):969-977.e2. doi: 10.1016/j.cmet.2022.05.003. Epub 2022 Jun 3.
7
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019.基于 2019 年全球疾病负担研究的全球五种病因原发性肝癌负担及 2035 年全球预测。
Cancer Med. 2022 Mar;11(5):1310-1323. doi: 10.1002/cam4.4551. Epub 2022 Feb 4.
8
The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.肝硬化及其潜在病因的负担:来自 2017 年全球疾病负担研究的结果。
Aging (Albany NY). 2021 Jan 12;13(1):279-300. doi: 10.18632/aging.104127.
9
Study of liver cirrhosis over ten consecutive years in Southern China.中国南方地区连续十年肝硬化研究。
World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.
10
Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis.肝癌的疾病负担、风险因素及近期趋势:一项全球国家层面分析
Liver Cancer. 2021 Jul;10(4):330-345. doi: 10.1159/000515304. Epub 2021 Mar 30.

引用本文的文献

1
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis.微生物群-癌症轴作为早发性肿瘤发生的一个潜在促成因素。
Med Oncol. 2025 Sep 6;42(10):464. doi: 10.1007/s12032-025-02988-8.
2
The Exposome Perspective: Environmental and Infectious Agents as Drivers of Cancer Disparities in Low- and Middle-Income Countries.暴露组视角:环境与感染因素作为低收入和中等收入国家癌症差异的驱动因素
Cancers (Basel). 2025 Jul 31;17(15):2537. doi: 10.3390/cancers17152537.
3
Liver, ageing and disease.肝脏、衰老与疾病。
Nat Rev Gastroenterol Hepatol. 2025 Jul 28. doi: 10.1038/s41575-025-01099-z.
4
Genetic evidence for the causal influence of inflammatory factors on intrahepatic cholangiocarcinoma risk.炎症因子对肝内胆管癌风险产生因果影响的遗传学证据。
World J Gastrointest Oncol. 2025 Jul 15;17(7):108455. doi: 10.4251/wjgo.v17.i7.108455.
5
Epidemiological Trends and Projection of Liver Cancer Due to Nonalcoholic Steatohepatitis Among People Aged 55 Years and Older in China From 1990 to 2030: An Analysis of the Global Burden of Disease Study 2021.1990年至2030年中国55岁及以上人群非酒精性脂肪性肝炎所致肝癌的流行病学趋势及预测:全球疾病负担研究2021分析
Clin Transl Gastroenterol. 2025 Jun 11;16(8):e00872. doi: 10.14309/ctg.0000000000000872. eCollection 2025 Aug 1.
6
Innovative Approaches in the Synthesis and Optimization of Copper Complexes for Antitumor Therapies: A Comprehensive Review.用于抗肿瘤治疗的铜配合物合成与优化的创新方法:综述
Molecules. 2025 May 9;30(10):2104. doi: 10.3390/molecules30102104.
7
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
8
Temporal trends and patterns for early- and late-onset adult liver cancer incidence vary by race/ethnicity, subsite, and histologic type in the United States from 2000 to 2019.2000年至2019年期间,美国早发性和晚发性成人肝癌发病率的时间趋势和模式因种族/族裔、亚部位和组织学类型而异。
Cancer Causes Control. 2025 May;36(5):551-560. doi: 10.1007/s10552-024-01955-4. Epub 2025 Jan 9.
9
Global Epidemiology of Hepatocellular Carcinoma.肝细胞癌的全球流行病学
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102446. doi: 10.1016/j.jceh.2024.102446. Epub 2024 Oct 28.
10
Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives.用于早期肝癌诊断和个性化医疗的即时检测:生物标志物、现有技术及展望
Heliyon. 2024 Sep 25;10(19):e38444. doi: 10.1016/j.heliyon.2024.e38444. eCollection 2024 Oct 15.

本文引用的文献

1
Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study.2017 年 29 种癌症的发病率和死亡率以及 1990 年至 2017 年的趋势分析,来自全球疾病负担研究。
J Hematol Oncol. 2019 Sep 12;12(1):96. doi: 10.1186/s13045-019-0783-9.
2
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.C-Myc 依赖性抑制两个致癌 miRNA 簇有助于雷公藤红素诱导肝癌细胞死亡。
J Exp Clin Cancer Res. 2018 Mar 9;37(1):51. doi: 10.1186/s13046-018-0698-2.
5
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
6
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究:1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
7
Serum microcystin levels positively linked with risk of hepatocellular carcinoma: A case-control study in southwest China.血清微囊藻毒素水平与肝细胞癌风险呈正相关:中国西南部的一项病例对照研究。
Hepatology. 2017 Nov;66(5):1519-1528. doi: 10.1002/hep.29310. Epub 2017 Sep 29.
8
Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.青少年乙型肝炎病毒疫苗加强免疫可降低高危成年人的HBV感染率。
Vaccine. 2017 Feb 15;35(7):1064-1070. doi: 10.1016/j.vaccine.2016.12.062. Epub 2017 Jan 6.
9
Natural postharvest aflatoxin occurrence in food legumes in the smallholder farming sector of Zimbabwe.津巴布韦小农户农业部门粮食豆类收获后天然黄曲霉毒素的出现情况。
Food Addit Contam Part B Surveill. 2017 Mar;10(1):21-26. doi: 10.1080/19393210.2016.1240245. Epub 2016 Oct 4.
10
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.

1990年至2017年全球、区域、国家、年龄和性别层面特定病因所致原发性肝癌的负担及趋势:全球疾病负担研究2017结果

The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017.

作者信息

Lin Longfei, Yan Lei, Liu Yuling, Qu Changhai, Ni Jian, Li Hui

机构信息

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Fengtai District Community Health Center, Beijing, China.

出版信息

Liver Cancer. 2020 Sep;9(5):563-582. doi: 10.1159/000508568. Epub 2020 Jul 23.

DOI:10.1159/000508568
PMID:33083281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7548973/
Abstract

BACKGROUND

Liver cancer is one of the leading causes of cancer-related deaths worldwide. The primary causes of liver cancer include hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol consumption, nonalcoholic fatty liver disease, and other factors.

AIMS

The objective of this study was to evaluate the global and sex-, age-, region-, country-, and etiology-related liver cancer burden, as well as the trends in liver cancer caused by different etiologies.

METHODS

The causes of liver cancer from 1990 to 2017, including global, regional, and national liver cancer incidence, mortality, and etiology, were collected from the Global Burden of Disease study 2017, and the time-dependent change in the trends of liver cancer burden was evaluated by annual percentage change.

RESULTS

The global liver cancer incidence and mortality have been increasing. There were 950,000 newly-diagnosed liver cancer cases and over 800,000 deaths in 2017, which is more than twice the numbers recorded in 1990. HBV and HCV are the major causes of liver cancer. HBV is the major risk factor of liver cancer in Asia, while HCV and alcohol abuse are the major risk factors in the high sociodemographic index and high human development index regions. The mean onset age and incidence of liver cancer with different etiologies have gradually increased in the past 30 years.

CONCLUSIONS

The global incidence is still rising and the causes have national, regional, or population specificities. More targeted prevention strategies must be developed for the different etiologic types in order to reduce liver cancer burden.

摘要

背景

肝癌是全球癌症相关死亡的主要原因之一。肝癌的主要病因包括乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、饮酒、非酒精性脂肪性肝病及其他因素。

目的

本研究的目的是评估全球及按性别、年龄、地区、国家和病因划分的肝癌负担,以及不同病因导致的肝癌趋势。

方法

收集了1990年至2017年肝癌的病因,包括全球、区域和国家的肝癌发病率、死亡率及病因,这些数据来自《2017年全球疾病负担研究》,并通过年度百分比变化评估肝癌负担趋势的时间依赖性变化。

结果

全球肝癌发病率和死亡率一直在上升。2017年有95万新诊断肝癌病例,超过80万人死亡,这是1990年记录数字的两倍多。HBV和HCV是肝癌的主要病因。HBV是亚洲肝癌的主要危险因素,而HCV和酒精滥用是社会人口统计学指数高和人类发展指数高的地区的主要危险因素。在过去30年里,不同病因肝癌的平均发病年龄和发病率逐渐上升。

结论

全球发病率仍在上升,病因具有国家、区域或人群特异性。必须针对不同病因类型制定更具针对性的预防策略,以减轻肝癌负担。